Parexel

Recapping an outstanding weekend at the Society for Clinical Research Sites (SCRS) Global Summit! Scroll through the pictures and read on for highlights from the event: 🏆 We were so incredibly proud to take home the Eagle Award in the CRO category for the second consecutive year! 🍵 We hosted our 10 "Next Generation" Site Scholarship recipients for a breakfast with program mentors and Parexel leaders to share their experiences and goals. 🔒 Nelly Nauman, EVP Corporate Technology and Chief Information Security Officer at Parexel, held a presentation covering emerging cyber security threats and steps sites can take to protect sensitive information. 🎤 Karen McIntyre MSc Clinical Trials, VP, Global Site Alliances, joined a panel discussion focused on enhancing communication between clinical sites and stakeholders. Later, she was part of an esteemed group that closed the conference by examining trends, challenges, and opportunities for clinical research sites. 💡 Marlenie Moodie, PT, CCRP, Senior Manager, Regional Feasibility Network, shared insights on improving site visibility with advice on how to become a partner site of choice. 🟰 Shanna Nixon, Director, Site Alliances, provided invaluable input on the multifaceted nature of diversity in the workplace and strategies to create thriving, inclusive environments within organizations. Thank you to everyone who stopped by our booth, joined our sessions, and all of our site partners for another amazing event! #SCRS2024 #EagleAward #SitePartnerships #ResearchSites #ClinicalResearch

📅 Mark your calendars! Join us this October for a series of insightful webinars. 🎆 Don't miss out on these 5 free learning opportunities with our clinical expert lineup! 1. Oct 1, 11:00 AM EDT: Accelerated Early Phase Decision Making - Insider Insights to Speed Development. https://lnkd.in/gBGMy9NS 2. Oct 2, 12:00 PM EDT: Highlights from ESMO 2024 - How does it affect drug development going forward. https://lnkd.in/ghw7GARj 3. Oct 3, 11:00 AM EDT: Leveraging post-marketing regulatory requirements to drive commercial value. https://lnkd.in/gJGj5g6n 4. Oct 23, 12:00 PM EDT: Navigating the Complexities of AML Drug Development - Expert Perspectives. https://lnkd.in/gf2EDVDV 5. Oct 29, 11:00 AM EDT: FDA Rare Disease Innovation Hub - Enhancing Collaboration and Speed. https://lnkd.in/gwd-eKib Register now to save your seat or receive a recording after the session! #Webinar #ClinicalResearch #ClinicalTrials #DrugDevelopment #EarlyPhase #ESMO24 #AML #RareDisease #FDA

"Patients are experts on their lived experiences, making them indispensable partners in drug development. As sponsors and CROs work to address unmet needs through new therapies, the patient’s voice should inform every aspect of the process." In this edition of the New Medicines, Novel Insights newsletter, Stacy Hurt 🌻, M.H.A., M.B.A., Chief Patient Officer, Kristina Reeder, Director, Patient Insights, and Nichola Gokool, Vice President, Customer Strategy and Innovation, Medical Communications, review the critical importance of the patient's voice throughout clinical development. Learn why this is so important in oncology trials, steps for understanding and amplifying patient perspectives, and how Parexel experts are tailoring research processes to the people the therapies are intended to serve. Read the full article and subscribe to receive the latest #NovelInsights each week! #Oncology #PatientsFirst #PatientPerspectives #PatientVoice

"Receiving this award two years in a row is a reflection of the efforts and innovative spirit of our global site-facing and site-supporting teams." - Teri Karcher Parexel has been awarded the 2024 Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category for the second consecutive year! This prestigious award underscores Parexel’s dedication to fostering strong partnerships with investigative sites and advancing patient-guided clinical research. Read the release or click through below to learn why Parexel took the prize two years in a row. 👇 https://lnkd.in/eZTyP2as #SCRS2024 #EagleAward #SitePartnerships

🏆 What an amazing night! Parexel has been awarded the Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category at the Global Site Solutions Summit for the second consecutive year! 🏆 We're deeply honored to be recognized by the global site community for our commitment to strong collaboration, which is fundamental to advancing drug development and better serving patients worldwide. A huge thank you to: ✨ Our wonderful site partners for their trust and collaboration. ✨ Our colleagues who work hard and are focused on maintaining strong site relationships every day. At Parexel, we're committed to creating better experiences for patients through meaningful collaboration with our site partners. We're grateful for your support and partnership! #SCRS2024 #EagleAward #SitePartnerships #ProudToBeParexel

We kicked off the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit with a special breakfast for recipients of Parexel's inaugural "Next Generation" Site Scholarship program. Our 10 scholarship recipients joined program mentors and Parexel leaders to share experiences and goals. The “Next Generation” Site Scholarship, designed exclusively for emerging investigative sites, offers a one-year SCRS membership with online training, a complimentary pass to #SCRS2024, mentoring sessions with experienced Site Alliance Program members and a dedicated Parexel Site Alliance Manager. It's inspiring to see these emerging sites networking, learning and setting goals to reach the next level in clinical research. At Parexel, we're committed to nurturing talent and shaping the future of our industry. Here's to the next generation of site investigators! 🚀 #ClinicalResearch #ResearchSites #SCRS #SitePartnerships

Your fast track to optimized drug development starts here – Register now! 🔜 Join Parexel’s Early Phase team and EQT Life Sciences on Oct. 1st for a live discussion on the benefits of early proof of concept data and best practices for expediting data generation through accelerated operational approaches that drive early decision-making. Access insider insights from combined perspectives of clinical pharmacology, global regulatory considerations, and private equity investors on accelerating early development timelines to go/no go decisions and early proof of concept, without shortcuts. 📅 Register now to attend or receive a recording of the exclusive insights shared: https://lnkd.in/g4dMXbhQ #EarlyPhase #Pharmacology #Regulatory #Webinar

Colleagues in Parexel's Newton, Mass. office gathered for a Lunch & Learn event in support of the Leukemia & Lymphoma Society (LLS) and our upcoming sponsorship and participation in Boston's Light the Night walk. Highlights included: 🏮 A presentation from Bridget Neville of LLS on the organization's mission and work 🏮 A moving patient story from acute myeloid leukemia (AML) survivor, John Ragan 🏮 Insights from our Emerging Leaders Jimmy Brown, hope morse and Beth Davis Heppenstall on fundraising for blood cancer research. We're proud to partner with LLS in support of blood cancer patients and look forward to culminating our effort when we #LightTheNight in Boston! ✨ #LLS #LeukemiaLymphomaSociety #ParexelWithHeart

Parexel is excited to enter a strategic alliance with DSP Clinical Research, a leading clinical research organization (CRO) specializing in reproductive endocrinology/fertility and women’s health research. 🔹 This alliance builds on our ongoing collaboration with DSP in the United States, providing customers an enhanced offering and level of expertise in this highly specialized area. 🔹 DSP's expertise in fertility studies along with Parexel's global capabilities is creating an unparalleled force and setting a new standard in women’s health research. We’re excited to accelerate sponsors’ development of safe and effective fertility therapies through our expanded collaboration and to improve patient outcomes. https://lnkd.in/eYEx7eim #Fertility #DSPClinical #PatientsFirst  

💡Can AI accelerate the future of clinical research and drug development?💡 We think so—and we’re excited to announce our participation at the 5th Annual Pharma AI Summit in London! Day 1 Highlights (Thursday, Sept. 26): 📅 8:50 – 9:00 a.m. Stephen Pyke, Chief Clinical Data & Digital Officer, will serve as the Day 1 Chairman. 📅 3:55 – 4:35 p.m. Stephen Pyke will moderate the panel “Getting to End-to-End AI-Enabled Clinical Trials Faster” featuring leaders from UCB, Bayer and Owkin. 📅 9:40 – 10:25 a.m. Martin Keywood, Scientific Data Technology Senior Director, will share use cases on “Realizing Value in AI in Drug Development.” Day 2 Highlights (Friday, Sept. 27): 📅 8:50 – 9:00 a.m. Stephen Pyke returns as Day 2 Chairman to kickstart another day of innovative discussions. We look forward to sharing how we’re leveraging AI to drive innovation in clinical trials and drug development! https://lnkd.in/gfidpYub #PharmaAISummit2024 #AIinHealthcare #DigitalInnovation #ClinicalTrials #AI